Christopher Hite (Evp & Chairman, Partnering) sold 117,592 shares of Royalty Pharma plc (RPRX) at $54.47 per share, totaling approximately $6.41M.
Insider sales can be driven by various factors including portfolio diversification, tax obligations, or pre-arranged trading plans and do not necessarily reflect a negative outlook.